2-Year Outcomes From the Largest Real-Life Global Registry Investigating Drug-Coated Balloon Angioplasty for Femoropopliteal Artery Disease: Time for a Treatment Shift Toward Drug Elution and Minimal Stenting?

Affiliations

¹ 2nd Department of Radiology, Interventional Radiology Division, Attikon University General Hospital, Athens, Greece. Electronic address: stavspiliop@med.uoa.gr.
² 2nd Department of Radiology, Interventional Radiology Division, Attikon University General Hospital, Athens, Greece.

Free article

Editorial

Stavros Spiliopoulos et al. JACC Cardiovasc Interv. 2018.

Free article

. 2018 May 28;11(10):954-956.

doi: 10.1016/j.jcin.2018.03.010.

¹ 2nd Department of Radiology, Interventional Radiology Division, Attikon University General Hospital, Athens, Greece. Electronic address: stavspiliop@med.uoa.gr.
² 2nd Department of Radiology, Interventional Radiology Division, Attikon University General Hospital, Athens, Greece.

No abstract available

Keywords: drug-coated balloons; endovascular treatment; femoropopliteal arterial disease.

Comment on

Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study.
Micari A, Brodmann M, Keirse K, Peeters P, Tepe G, Frost M, Wang H, Zeller T; IN.PACT Global Study Investigators. Micari A, et al. JACC Cardiovasc Interv. 2018 May 28;11(10):945-953. doi: 10.1016/j.jcin.2018.02.019. JACC Cardiovasc Interv. 2018. PMID: 29798770 Clinical Trial.